BF Biosciences Limited (PSX:BFBIO)
Pakistan
· Delayed Price · Currency is PKR 131.13
-7.73 (-5.57%)
At close: Mar 9, 2026
BF Biosciences Revenue
BF Biosciences had revenue of 2.67B PKR in the quarter ending December 31, 2025, with 101.03% growth. This brings the company's revenue in the last twelve months to 8.22B, up 81.98% year-over-year. In the fiscal year ending June 30, 2025, BF Biosciences had annual revenue of 5.84B with 59.55% growth.
Revenue (ttm)
8.22B
Revenue Growth
+81.98%
P/S Ratio
1.41
Revenue / Employee
15.37M
Employees
535
Market Cap
11.58B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samba Bank | 7.08B |
| Century Paper & Board Mills | 37.14B |
| Siemens (Pakistan) Engineering | 9.15B |
| Atlas Insurance | 5.76B |
| Ittehad Chemicals | 30.57B |
| The Thal Industries Corporation | 42.27B |
| Macter International | 11.58B |
| Barkat Frisian Agro | 7.44B |